Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.

Also called NCT02351050

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 144 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02351050
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Slovakia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02351050. Randomized; single masking; primary purpose prevention. Start 2015-04 (actual); primary completion 2017-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sonolysis in Risk Reduction of Symptomatic and Silent Brain Infarctions During Coronary Stenting
Intervention (Device)
Sonolysis
Intervention (Other)
Sham procedure
Lead sponsor
University Hospital Ostrava (class: other)

Record details

Record id
cardio:ct-nct02351050
Content hash
9fe18316283db17d1e7394ac457cf042ec898c270f9c3164271e95cc725dffd0